Cell Therapy



Marcus O. Muench, PhD, is a senior scientist at BSRI and an Associate Adjunct Professor in the Department of Laboratory Medicine at the University of California San Francisco (UCSF). Dr. Muench received his AS degree from the College of Marin and BS degree from the University of California, Davis. He earned his PhD from Weill Cornell Graduate School of Medical Sciences working in the Laboratory of Developmental Hematopoiesis at the Sloan-Kettering Institute. Dr. Muench received post-doctoral training in the Human Immunology Department at DNAX Research Institute for Cellular and Molecular Biology before joining the faculty of the Fetal Treatment Center at UCSF.

  • Marcus Muench, PhD

    Marcus Muench, PhD

  • Contact
  • Current Positions
  • Links
  • Education and Training
  • Publications
  • Lab Members

Marcus O. Muench, PhD
270 Masonic Ave.
San Francisco, CA 94118
Click Here For Email  
Phone: (415) 901-0747
Fax: (415) 567-5899

  • Senior Scientist, BSRI
  • Associate Adjunct Professor, UCSF Department of Laboratory Medicine
  • AS, Physical Sciences, College of Marin, Kentfield, CA
  • BS, Genetics, University of California, Davis, CA
  • PhD, Cell Biology and Genetics, Weill Cornell Graduate School of Medical Sciences, New York, NY
  • Post-Doctoral Fellow, DNAX Research Institute of Molecular and Cellular Biology, Palo Alto, CA
Image of Alan Gutierrez

Alan Gutierrez
Research Associate I
Click Here For Email  
Phone:(415) 923-5771 ext.219

Image of Dylan Hampton

Dylan Hampton
Research Associate II
Click Here For Email  
Phone: (415) 923 - 5771 ext.257

Image of Priya Togarrati

Padma Priya Togarrati, PhD
Staff Scientist I
Click Here For Email  
Phone:(415) 923-5771 ext.353

  • Stem Cells and Cellular Therapy

    Our group is studying the use of various cell and stem cell populations for application in new cellular therapies. The main focus is on the development of various stem cell populations. Current projects focus on cell therapy for hemophilia A, the development of blood-forming tissues, and the development of mesenchymal stromal cell populations.

  • Modeling of Transfusion

    Our group is working on the development of safer and better blood products. We have developed in vivo models to evaluate pathogen inactivation technologies and to test the efficacy of new blood components.

  • Modeling Infectious Disease

    Viruses and parasites pose a threat to the blood supply as evidenced by the recent widespread outbreaks of Chikungunya and Zika viruses. Our group is using in vitro and vivo models to help study various pathogenic organisms to better understand the risk that they pose to the blood supply and to help develop vaccine and therapeutic options.